By Joshua Burd As one of the state’s fastest-growing firms, Hollister Construction Services has bolstered its team with an executive who is well-versed in managing large-scale construction portfolios. The Parsippany-based firm has hired Christopher Cestone as its new vice president…
Health Care & Education
The health care and education sectors are undergoing dramatic changes. So are their real estate needs.
High hopes for life sciences
For all the time we’ve spent highlighting New Jersey’s glut of sprawling, vacant corporate campuses, it’s easy to lose sight of just how many of them have been rescued in recent years by some of the state’s boldest and most inventive developers. Those success stories are worth telling, which is why we often do at Real Estate NJ. But there are underlying trends or nuances in some of those projects that don’t get as much attention on a day-to-day basis. Like how a crop of innovative, lesser-known biotech and pharmaceutical firms are backfilling space at the former research campuses of Sanofi and Hoffmann-LaRoche, helping to stabilize those sites as their new owners pursue larger redevelopment plans.
Shifts in workplace, demographics in focus at Roche site redevelopment forum
Local residents were among those who turned out this week for a forum tied to Prism Capital Partners’ plans for the former Hoffmann-LaRoche campus in Nutley and Clifton, as the developer sought to highlight the shifts in demographics, corporate strategy and lifestyle choices that are now driving New Jersey’s economy.
